This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. Abstract Background: CAPTsure (Clinical Assessment of PTS) is a new tool for diagnosis and severity rating of pediatric postthrombotic syndrome (PTS). Our objective was to test the reliability, measurement error, and minimal detectable change of CAPTSure. Methods: Children aged newborn to 18 years who sustained upper extremity or lower extremity deep vein thrombosis (DVT) were enrolled ≥ 6 months after DVT diagnosis. Patients were assessed by 2 raters to determine the reliability of the clinician assessment component (CC) of CAPTSure. Patients/proxies completed CAPTSure at baseline and approximately 2 weeks later to assess test-retest reliability of the symptoms component (SC). Results: Of 148 patients enrolled in the study; 30 had sustained either bilateral or both upper and lower extremity DVT. Hence, 178 extremities were assessed for PTS signs (86 upper extremity, 92 lower extremity). Intraclass correlation coefficient (ICC) for the CC was 0.89 (95% confidence interval [CI], 0.84-0.93) for upper extremity and 0.88 (95% CI, 0.83-0.92) for lower extremity. Nonclinicians performed 59% of measurements. Ninety-eight patients completed the SC at baseline and follow-up, for a total of 60 upper extremity and 61 lower extremity assessments. ICC for the SC was 0.89 (95% CI, 0.84-0.93) for upper extremity and 0.92 (0.87-0.95) for lower extremity. ICC for CAPTSure was 0.92 (95% CI, 0.87-0.95) for upper extremity and 0.93 (95% CI, 0.88-0.95) for lower extremity assessment. Measurement error ranged between 1.7 and 4.3 of 100 points. A change of approximately 11 of 100 points in CAPTSure score would be required to be confident that there was a change in PTS severity. Conclusion: CAPTSure has excellent reliability and a small measurement error, even when applied by nonhematologists. K E Y W O R D S child, infant, lower extremity, postthrombotic syndrome, reproducibility of results, surveys and questionnaires, upper extremity 0.88 (0.83-0.92) 1.5 (1.2-1.8) CAPTSure, upper extremity subindex (n = 60) 0.92 (0.87-0.95) 4.3 (3.7-5.2) CAPTSure, lower extremity subindex (n = 61) 0.93 (0.88-0.95) 3.8 (3.2-4.6)
| INTRODUCTION
Postthrombotic syndrome (PTS) is a long-term consequence of deep vein thrombosis (DVT), diagnosed by the presence of characteristic signs and symptoms. 1 The index for the Clinical Assessment of PTS (CAPTSure) is a tool developed for the diagnosis and severity rating of PTS in children. 2, 3 Whereas PTS signs are measured by the clinician using a clinician assessment component, PTS symptoms are reported by either the patient or their proxy, according to the age of the child being assessed, using a patient/proxy questionnaire component. The scores of signs and symptoms are combined to obtain a final score that ranges from 0 to 100 points, which are indicative of PTS severity of the upper or lower extremity; 100 points indicate the worst possible PTS. The scoring system takes into account the importance that health care providers and patient/parents assigned to each sign and symptom during the development of the tool. 3 Upper and lower extremities are assessed separately by means of specific subindexes. The items and responses of each subindex can be seen in Appendix S1.
CAPTSure was developed as a formative measure. Formative measurement models can be distinguished from the reflective models commonly used in psychology by a number of characteristics including correlation among items, direction of causality between the construct and its items, and nature of the construct. 4 The study of test-retest reliability and interrater reliability is recommended for formative measures. 5, 6 Reliability in this context can be related to the temporal stability of the index. The concept is similar to the "reliability/precision" aspect of reliability described in measurement in education and psychology, 7, 8 and it is determined on the basis of obtaining consistent results when the testing is replicated.
Importantly, the construct being measured would be expected to remain stable between replications. 8 Reliability is context specific and depends on the study sample. 9, 10 Variation in the results obtained through repeated testing reflect the presence of measurement error. 7, 11 Measurement error of a tool is considered to be more stable than its reliability when the tool is applied to different samples, 10 and it provides information about the precision of the scores. 12 In the context of PTS, the stability of scores over time obtained by assessment tools such as CAPTSure can be influenced not only by the reliability of the measurement instrument itself but also by changes in the individual applying the instrument and by true changes in PTS. 7, 9 For example, scores of items that assess PTS symptoms can change due to oscillation of symptoms and differences within the subject between occasions not related to changes in the phenomenon 7 ;
test-retest reliability becomes relevant in this case. The variability in the scoring of items that assess PTS signs can be due to differences among clinical raters and differences in the measurement procedure;
in view of such variability, interrater reliability is of interest.
Assessing the reliability of tools used in clinical practice is critical, as it allows clinicians to interpret why scores change over time and, therefore, be confident when making clinical decisions based on these tools. 8, 13 This study aimed to evaluate the reliability and measurement error of CAPTSure for the assessment of upper and lower extremity PTS as separate subindices. In addition, minimum detectable change (MDC) for each subindex was estimated.
| METHODS
This prospective study enrolled newborns to children aged up to 18 years old, who sustained upper and/or lower extremity DVT at least 6 months prior to study participation and were followed up at the Thrombosis Clinic in The Hospital for Sick Children, Toronto, Ontario, Canada.
Given an anticipated intraclass correlation coefficient (ICC) of 0.80, we estimated that the measurement of 60 upper and 60 lower extremities by either 2 raters or in 2 testing occasions, for a total of 120 upper and 120 lower extremity measurements overall, would provide an acceptable expected width of the 95% confidence interval (CI) of 0.2. 14 Assuming a 30% to 35% loss to follow up for testretest and the fact that approximately 15% to 20% of patients were expected to have >1 extremity affected by DVT, 15 we estimated that a sample of 140 to 150 patients would allow us to reach the goal of obtaining measurements on 60 upper and 60 lower extremities.
At the time of study enrollment, 2 assessors measured PTS signs applying the clinician assessment component of CAPTSure, which includes the assessment of thigh and calf circumference difference and ulcers for the lower extremity and arm circumference difference and collaterals for the upper extremities (Appendix S1). Assessors took 3 measurements, as previously described, 2 and averaged the obtained values to determine limb circumference difference. In addition, the assessor evaluated pain intensity in children aged 4 to 9 years using the Faces Pain Scale-Revised (FPS-R). 16 Assessments were performed independently.
The assessors were trained to apply CAPTSure either in person or using online educational material 17 and were assigned to evaluate each patient from a pool of clinicians and research team members according to availability.
Essentials
• CAPTSure (Clinical Assessment of PTS) is a tool for diagnosis and severity rating of pediatric postthrombotic syndrome (PTS).
• We tested its reliability, measurement error (ME), and minimal detectable change (MDC).
• CAPTSure showed excellent reliability and small ME, even when applied by nonhematologists.
• A change of 11 of 100 points would indicate that there was a change in PTS severity, as per the MDC. PTS symptoms were reported by patients or proxies, according to the age of the child (older or younger than 10 years), by completing the patient/proxy questionnaire component of CAPTSure.
This questionnaire assesses the frequency of heaviness, tired limb sensation, swelling, skin redness, tightness, and paresthesia of the affected limb (Appendix S1). Children aged 10 years and older self-reported pain intensity using the FPS-R. An electronic version of the questionnaire developed using REDCap 18 was used in the study.
After study enrollment, patients or proxies were requested to complete the symptoms questionnaire at baseline and 14 days after the first assessment. It was expected that PTS would remain stable in this period of time, thus allowing the assessment of temporal stability of scores. 7 Interrater reliability and 95% CI for the clinician assessment component of CAPTSure (ie, PTS sign measurement) and test-retest reliability and 95% CI for the patient/proxy questionnaire component of CAPTSure (ie, PTS symptom measurement) for each subindex were estimated using linear mixed models to take into account the nested nature of the data (ie, that some patients had more than one extremity assessed). Confidence intervals were calculated using a para- that would be needed to consider a real change in PTS severity, beyond measurement error. 12, 19 Statistical analysis was performed using R (R Core Team 2017, R Foundation for Statistical Computing, Vienna, Austria), using the lme4 package. 20 Informed consent and assent, when applicable, were obtained prior to study participation. The study was approved by the hospital Research Ethics Board.
| RESULTS
In total, 148 patients were enrolled in the study between November 2016 and December 2017 at a median of 4.4 years after DVT diagnosis (range, 6.1 months to 17.7 years).
Characteristics of the included patients are shown in Table 1 . Table 2 ). Subanalysis of the patient vs. proxy responses showed an ICC of 0.92 (95% CI, 0.87-0.95) for self-report and an ICC of 0.61 (95% CI, 0.44-0.74) for proxy-reported symptoms.
Because early responses may increase reliability due to respondents recalling previous answers, we analyzed a subsample of retest responses provided <10 days from the first assessment. The analysis showed an ICC of 0.54 (95% CI, 0.16-0.77).
Reliability and measurement error of the CAPTSure subindexes for the assessment of upper and lower limbs are shown in Table 2 .
According to the measurement error results, a minimal detectable change of 11.9 and of 10.5 of 100 points in CAPTSure scores would be required to convincingly indicate a change in PTS severity when assessing upper and lower extremities, respectively. 
TA B L E 1 Characteristics of patients

| DISCUSSION
In the present study population, CAPTSure showed excellent reliability 13 in the assessment of PTS in the upper and lower extremities in children. Therefore, we can be confident of the level of agreement when applying CAPTSure, even when the tool is applied by nonhematologists.
In addition to CAPTSure, 2 other tools are available for the di- TA B L E 2 Reliability and measurement error of CAPTSure and its components operating characteristic curve analysis of the same data showed that 10 points was the threshold score that would discriminate normal from below normal activity and participation scores, as measured by the Pediatric Outcomes Data Collection Instrument 32 (unpublished data).
Equal weighting and simple summation of items to obtain an overall score, as used in most PTS tools, result in a score that linearly represents disease severity. 33 This interpretation of the overall score can be problematic, particularly when adding ordinal subscales. 34 The approach to deriving item weights in CAPTSure allowed for the transformation of its ordinal items into an interval overall score, 35 which has sound mathematical properties that enable the estimation of a meaningful measurement error and minimal detectable change.
Our study should be interpreted in the light of potential limitations. One-third of patients enrolled in the study did not provide a second assessment in the evaluation of test-retest reliability, which could have led to a more homogeneous sample of patients and affected the reliability results (lower ICC). Of note, potential attrition was taken into account when designing the study sample size. In addition, in the assessment of test-retest reliability, it is considered that a short interval between administrations of a test can lead to increased reliability due to patients remembering their first responses. 10 However, subanalysis of responses provided <10 days or sooner did not show higher reliability of the sample.
In conclusion, CAPTSure is a newly developed tool for the assessment of pediatric PTS, which shows excellent reliability and small measurement error, even when applied by nonhematologists.
Therefore, CAPTSure is an adequate instrument for use in clinical practice and research. 
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